Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

VETMEDIN-FDA

More Like This

World's First Patent Acquired for Animal Supplement "Pinfenon" (S) (R)

Business Wire logo

Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats

PR Newswire associated0

Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus

PR Newswire associated0

Funding secured for CE approval of the groundbreaking C-MIC device from Berlin Heals Holding AG

PR Newswire associated0

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

PR Newswire associated0

Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval

Introducing PBC BioVet: A New Frontier in Veterinary Healthcare

PR Newswire associated0

Boehringer Ingelheim Partners with Veeva to Advance its Clinical and Regulatory Operations in Animal Health